Dr Simon Best joins Aquapharm as chief executive
Published on: 13/04/10
Aquapharm has appointed Dr Simon Best (pictured) chief executive in a move that sees the Scottish marine biotechnology company’s current head and founder Andrew Mearns Spragg move to a new role as chief technical officer.
Dr Best has held previous positions as chief executive of Roslin BioMed, and chairman of Ardana and the UK BioIndustry Association.
He is a visiting professor at the University of Edinburgh and remains the chair of the BioQuarter Commercialisation Board.
His predecessor in the role Andrew Mearns Spragg said: “I would like to welcome Simon to Aquapharm, a company for which I have endless passion, having founded and developed it over the past 10 years.”
Best's appointment comes as Aquapharm closes a £4.2 million investment from existing investors Aescap Venture, Tate & Lyle Ventures, Highlands and Islands Enterprise and NESTA.
The additional finance will be used towards the further development and commercialisation of Aquapharm's product portfolio produced from over 7,250 marine micro-organisms.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
